跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Ambrorex
Approved
STANDARD
Ambrorex
Next Wave (India)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d5a336627bd9ce32
Company
Next Wave (India)
Type
Standard
Approval Details
Approval Id
d5a336627bd9ce32
Drug Approval Philippines Name
Ambrorex
Product Name
Ambrorex
Registration Number
DRP-11966
Brand Name
Ambrorex
Generic Name
Ambroxol
Dosage Form
Tablet
Dosage Strength
30 mg
Manufacturer
Next Wave (India)
Importer
Aarex Pharma Distributor
Distributor
Aarex Pharma Distributor
Issuance Date
24 May 2022
Expiry Date
24 May 2027
Pharmacologic Category
Mucolytic
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d5a336627bd9ce32
Type
Standard
Back to Philippines FDA Approvals
Ambrorex - Philippines FDA Drug Approval Details